JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FPRX
4001
CALL
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $536K | ﹤0.01% |
+40,000
| New | +$456K |
2019 Q1
0 quarters
|
|
|
FPRX
4002
PUT
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $536K | ﹤0.01% |
+40,000
| New | +$456K |
2019 Q1
0 quarters
|
|
4003
iShares US Consumer Discretionary ETF
IYC
$1.19B
| $532K | ﹤0.01% |
10,420
+996
| +11% | +$49K |
2013 Q2
23 quarters
|
|
4004
Scholastic
SCHL
$687M
| $532K | ﹤0.01% |
13,367
-33,782
| -72% | -$1.39M |
2015 Q3
14 quarters
|
|
4005
Comscore
SCOR
$65.3M
| $531K | ﹤0.01% |
+1,311
| New | +$533K |
2019 Q1
0 quarters
|
|
|
PZN
4006
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $530K | ﹤0.01% |
65,492
+1,553
| +2% | +$13.9K |
2017 Q3
6 quarters
|
|
4007
Pacira BioSciences
PCRX
$981M
| $529K | ﹤0.01% |
13,905
-409
| -3% | -$16K |
2013 Q2
23 quarters
|
|
4008
Safe Bulkers
SB
$976M
| $528K | ﹤0.01% |
361,581
+303,020
| +517% | +$501K |
2017 Q4
5 quarters
|
|
4009
Argan
AGX
$5.72B
| $527K | ﹤0.01% |
10,561
-52,335
| -83% | -$2.36M |
2013 Q2
23 quarters
|
|
4010
Gorman-Rupp
GRC
$2.06B
| $527K | ﹤0.01% |
15,551
+10,128
| +187% | +$341K |
2015 Q4
13 quarters
|
|
4011
Teekay Tankers
TNK
$3.52B
| $526K | ﹤0.01% |
67,846
-3,844
| -5% | -$31.4K |
2016 Q4
9 quarters
|
|
4012
Buckle
BKE
$2.22B
| $525K | ﹤0.01% |
28,028
-76,545
| -73% | -$1.4M |
2014 Q4
17 quarters
|
|
4013
State Street SPDR S&P Transportation ETF
XTN
$301M
| $525K | ﹤0.01% |
8,695
+6,322
| +266% | +$377K |
2017 Q1
8 quarters
|
|
4014
Invesco DB Base Metals Fund
DBB
$363M
| $523K | ﹤0.01% |
30,649
-480
| -2% | -$7.8K |
2017 Q1
8 quarters
|
|
|
WSR
4015
DELISTED
Whitestone REIT
WSR
| $523K | ﹤0.01% |
43,521
-81,427
| -65% | -$1.08M |
2017 Q3
6 quarters
|
|
|
SAFE
4016
DELISTED
Safehold Inc.
SAFE
| $523K | ﹤0.01% |
23,989
+5,783
| +32% | +$108K |
2017 Q4
5 quarters
|
|
4017
PUT
Vanguard Information Technology ETF
VGT
$160B
| $522K | ﹤0.01% |
+20,800
| New | +$483K |
2019 Q1
0 quarters
|
|
|
LUMO
4018
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $521K | ﹤0.01% |
29,969
-75,642
| -72% | -$1.13M |
2016 Q4
9 quarters
|
|
4019
CALL
National Beverage
FIZZ
$2.81B
| $520K | ﹤0.01% |
+18,000
| New | +$640K |
2019 Q1
0 quarters
|
|
4020
Takeda Pharmaceutical
TAK
$57.4B
| $520K | ﹤0.01% |
25,518
-43,660
| -63% | -$879K |
2018 Q4
1 quarter
|
|
4021
Airgain
AIRG
$55.7M
| $519K | ﹤0.01% |
40,485
+1,300
| +3% | +$15.3K |
2017 Q4
5 quarters
|
|
4022
Shake Shack
SHAK
$2.63B
| $519K | ﹤0.01% |
8,776
-116
| -1% | -$5.94K |
2015 Q3
14 quarters
|
|
|
CORV
4023
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $519K | ﹤0.01% |
164,148
-66,433
| -29% | -$215K |
2015 Q4
13 quarters
|
|
|
LKFT
4024
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.92B
| $518K | ﹤0.01% |
+4,395
| New | +$443K |
2019 Q1
0 quarters
|
|
4025
PUT
Kinross Gold
KGC
$27.6B
| $516K | ﹤0.01% |
+150,000
| New | +$500K |
2019 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.